Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)
Clinical trial NCT00993187 · COMPLETED
Trial details
- NCT number
- NCT00993187
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-04
- Primary completion
- 2013-10-29
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.